Detalhe da pesquisa
1.
Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.
Clin Drug Investig
; 32(2): 99-110, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22117178